Orivet Partners with Eurofins to Improve Microbiome Analysis

Leading international personalized medicine and genetic testing provider Orivet Genetic Pet Care partners with Eurofins Laboratories.

RAMSEY, N.J., July 7, 2022 /PRNewswire-PRWeb/ -- Orivet Genetic Pet Care, a leading international personalized medicine and genetic testing organization, recently announced a partnership with Eurofins Laboratories, a global leader in analytical testing in the bio/pharmaceutical, food, environment, and medical device industry based in Europe.

The partnership will be centered on both organizations' commitment to improving current animal gut microbiome analysis. Microbiome testing is identifying and sequencing microbial DNA material from an animal. Currently, testing provides a comprehensive report on the composition of a dog, cat and horse gut microbiome population ? a collection of hundreds of different types of bacteria and other microbes (viruses, fungi, etc.) in an animal's GI tract.

Like humans, healthy biomes are essential for an animal's overall health. From understanding nutrient availability and gut health to being instrumental in diagnosing inflammatory disorders, gut microbiome analysis gives pet owners and veterinarians an overview of the pet's gut health and much more. With microbiome analysis, owners can identify nutritional deficiencies and gut imbalances that can impact digestion, skin allergies and even behavior. Reports provide actions and recommendations to restore their pet's healthy microbiome.

"We are extremely excited about this opportunity to collaborate with [Eurofins], said Noam Pik, CEO of Orivet. "With our industry-leading work in evidence-based pet care, coupled with their European presence and capabilities in applied genomics, we are excited to deliver this advanced innovative testing to our customers in Europe and around the world."

About Orivet Genetic Pet Care
Orivet Genetic Pet Care is a leading personalized-medicine organization offering innovative health care solutions for breeders, veterinarians, and pet owners. The organization was founded in 2010, on the premise that each pet is unique, with its own set of specific traits, behaviors, genetic health needs, and inherent risks. Orivet works with veterinarians, pet owners, and responsible pet breeders to provide practical, evidence-based platforms focused on identifying risk and improving clinical outcomes.

To learn more about Orivet Genetic Pet Care, please visit https://www.orivet.com

About Eurofins
Eurofins is Testing for Life. Eurofins is the global leader in food, environment, pharmaceutical and genomic testing, and in discovery pharmacology, forensics, advanced material sciences and agroscience Contract Research services. Eurofins is also a market leader in certain testing and laboratory services for genomics, in the support of clinical studies, and in BioPharma Contract Development and Manufacturing. The Group also has a rapidly developing presence in highly specialized and molecular clinical diagnostic testing and in-vitro diagnostic products.

Media Contact

[email protected], Orivet, 1 18006630126, [email protected]

SOURCE Orivet